Sarah Warner
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Sepsis Diagnosis and Treatment 3
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Sameer S. Kadri (30 shared papers)Ahmed Babiker (11 shared papers)Michael Klompas (10 shared papers)Jeffrey R. Strich (11 shared papers)Robert L. Danner (8 shared papers)Yi Ling Lai (6 shared papers)John P. Dekker (7 shared papers)Alex Mancera (10 shared papers)
- Journals
- The Lancet Infectious Diseases (5 papers)Open Forum Infectious Diseases (5 papers)JAMA Network Open (4 papers)Clinical Infectious Diseases (3 papers)Annals of Internal Medicine (3 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Sarah Warner
33 papers receiving 981 citations
Sarah Warner's Hit Papers
Peers
Comparison fields: 5 of 96
- Applied Microbiology and Biotechnology 92
- Molecular Medicine 101
- Clinical Biochemistry 96
- Infectious Diseases 180
- Endocrinology 41
Countries citing papers authored by Sarah Warner
This map shows the geographic impact of Sarah Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Warner more than expected).
Fields of papers citing papers by Sarah Warner
This network shows the impact of papers produced by Sarah Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Warner. The network helps show where Sarah Warner may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah Warner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 171 | |
| 2 | Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021 Hit paper breakdown → | 2022 | 138 |
| 3 | 2020 | 126 | |
| 4 | 1999 | 70 | |
| 5 | 2013 | 65 | |
| 6 | 2020 | 59 | |
| 7 | 2006 | 51 | |
| 8 | 2022 | 39 | |
| 9 | 2022 | 38 | |
| 10 | 2014 | 30 | |
| 11 | 2020 | 26 | |
| 12 | 2024 | 25 | |
| 13 | 2021 | 24 | |
| 14 | 2020 | 24 | |
| 15 | 2024 | 12 | |
| 16 | 2023 | 12 | |
| 17 | 2018 | 12 | |
| 18 | 2024 | 9 | |
| 19 | 2024 | 8 | |
| 20 | 2024 | 8 |
About Sarah Warner
Sarah Warner is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Oncology and Cancer Research, having authored 36 papers that have together received 997 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Streptococcal Infections and Treatments (3 papers), Antibiotic Resistance in Bacteria (3 papers), Sepsis Diagnosis and Treatment (3 papers), Antibiotic Use and Resistance (3 papers), COVID-19 and healthcare impacts (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Disaster Response and Management (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (92 citations), Molecular Medicine (101 citations), Clinical Biochemistry (96 citations), Infectious Diseases (180 citations) and Endocrinology (41 citations). Sarah Warner has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Sameer S. Kadri, Ahmed Babiker, Michael Klompas, Jeffrey R. Strich, Robert L. Danner, Yi Ling Lai, John P. Dekker, Alex Mancera, Cumhur Y. Demirkale and Junfeng Sun. Their work appears in journals such as The Lancet Infectious Diseases, Open Forum Infectious Diseases, JAMA Network Open, Clinical Infectious Diseases and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.